Approximately 20% of general population in the United States has fatty liver, which is associated with obesity, alcohol drinking, metabolic disease, medications, type 2 diabetes. The prevalence of fatty liver is expected to further increase at alarming rate due to the overall increase in the prevalence of obesity. For example, currently, about 22.5% of U.S. citizens are obese, and this prevalence is expected to reach 40% by the year 2025. Fatty liver is a significant risk factor for serious liver disease. However, the molecular mechanism underlying fatty liver development is not clear and there is no pharmacologic agent that is known to prevent or reverse fatty liver disease. Mitochondrial dysfunction caused by oxidative stress is an early event that plays an important role in the pathogenesis of alcohol-induced apoptosis and steatosis. We hypothesize that the protective role of IL-6 in alcohol-induced liver injury is mediated via suppression of alcohol-induced oxidative stress and mitochondrial dysfunction. To test this hypothesis, we examined the effects of IL-6 on alcohol-induced oxidative stress, mitochondrial injury, and energy depletion in the liver of IL-6 (-/-) mice and hepatocytes from alcohol-fed rats or genetically obese Zucker rats. Alcohol consumption leads to stronger induction of malondialdehyde (MDA) in IL-6 (-/-) mice compared to wild-type control mice, which can be corrected by administration of IL-6. In vitro, IL-6 treatment prevents alcohol-mediated induction of reactive oxygen species (ROS), MDA, and mitochondrial permeability transition (MPT), and alcohol-mediated depletion of adenosine triphosphate (ATP) in hepatocytes from alcohol-fed rats or steatotic Zucker rats. Administration of IL-6 in vivo also reverses alcohol-induced steatosis, MDA, and ATP depletion. Finally, IL-6 treatment markedly induces metallothionein protein and mRNA expression, but not superoxide dismutase and glutathione peroxidase in cultured hepatocytes. In conclusion, IL-6 protects against alcohol-induced oxidative stress and mitochondrial dysfunction in hepatocytes via, at least in part, induction of metallothionein protein expression, which may account for the protective role of IL-6 in alcoholic liver disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Intramural Research (Z01)
Project #
1Z01AA000369-01
Application #
6675122
Study Section
(LPS)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Alcohol Abuse and Alcoholism
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Oh, Yumin; Park, Ogyi; Swierczewska, Magdalena et al. (2016) Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells. Hepatology 64:209-23
Park, Ogyi; Jeong, Won-Il; Wang, Lei et al. (2009) Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 49:1683-94
Jeong, Won-Il; Gao, Bin (2008) Innate immunity and alcoholic liver fibrosis. J Gastroenterol Hepatol 23 Suppl 1:S112-8
Oh, Yeo Kyoung; Lee, Hyun Jung; Jeong, Mi-Hee et al. (2008) Role of activating transcription factor 3 on TAp73 stability and apoptosis in paclitaxel-treated cervical cancer cells. Mol Cancer Res 6:1232-49
Kunos, George; Gao, Bin (2008) Endocannabinoids, CB1 receptors, and liver disease: hitting more than one bird with the same stone. Gastroenterology 134:622-5
Horiguchi, Norio; Ishac, Edward J N; Gao, Bin (2007) Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation. Alcohol 41:271-80
Cui, Yongzhi; Hosui, Atsushi; Sun, Rui et al. (2007) Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 46:504-13
Donohue Jr, Terrence M; Cederbaum, Arthur I; French, Samuel W et al. (2007) Role of the proteasome in ethanol-induced liver pathology. Alcohol Clin Exp Res 31:1446-59
Batkai, Sandor; Osei-Hyiaman, Douglas; Pan, Hao et al. (2007) Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J 21:1788-800
Moh, Akira; Iwamoto, Yoshiki; Chai, Gui-Xuan et al. (2007) Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery. Lab Invest 87:1018-28

Showing the most recent 10 out of 20 publications